Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 1
| |||||||
Emmaus Life Sciences, Inc.
| 3.76M |
$0.29 | $1,090,685.07 | +373.17% | 4.77M |
Jan 18 - Dec 15
| |||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 18
| |||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 12
| |||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Emmaus Life Sciences, Inc.
| 40K |
$4.25 | $170,000.00 | +11.93% | 375.31K |
Sep 9
| |||||||
Emmaus Life Sciences, Inc.
| 12.54K |
$4.20 | $52,689.00 | +3.89% | 335.31K |
Sep 6
| |||||||
Emmaus Life Sciences, Inc.
| 52.89K |
$3.89 | $205,700.40 | +19.60% | 322.76K |
Sep 4 - Sep 5
| |||||||
Emmaus Life Sciences, Inc.
| 3.4K |
$3.30 | $11,220.00 | +1.28% | 269.87K |
Aug 30
| |||||||
Emmaus Life Sciences, Inc.
| 2.35K |
$2.80 | $6,566.00 | +0.89% | 266.47K |
Aug 28
| |||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Emmaus Life Sciences, Inc.
| 454.55K |
$6.60 | $2,999,997.00 | +454.54% | 554.54K |
Jul 9
| |||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Emmaus Life Sciences, Inc.
| 100K |
$10.00 | $1,000,000.00 |
∞
| 100K |
Dec 18
| |||||||
Emmaus Life Sciences, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||